Goldman Sachs & Co. LLC Form 38.5b - UDG Healthcare plc (6089I)

TIDMUDG

RNS Number : 6089I

Goldman Sachs & Co. LLC

13 August 2021

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

 
 Name of exempt principal trader            GOLDMAN SACHS & CO. LLC 
 Company dealt in                              UDG HEALTHCARE PLC 
                                           ------------------------- 
 Class of relevant security to which the    EUR 0.05 ordinary shares 
  dealings being disclosed relate (Note1) 
                                           ------------------------- 
 Date of dealing                                 12 August 2021 
                                           ------------------------- 
 

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 
                                                       Long               Short 
                                                 Number      (%)     Number    (%) 
                                               ----------  -------  -------  ------- 
 (1) Relevant securities                        3,666,937   (1.45)   66,833   (0.02) 
                                               ----------  -------  -------  ------- 
 (2) Derivatives (other than options)               0       (0.00)     0      (0.00) 
                                               ----------  -------  -------  ------- 
 (3) Options and agreements to purchase/sell        0       (0.00)     0      (0.00) 
                                               ----------  -------  -------  ------- 
 Total                                          3,666,937   (1.45)   66,833   (0.02) 
                                               ----------  -------  -------  ------- 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 
 Class of relevant security:                       Long          Short 
                                               Number   (%)   Number   (%) 
                                              -------  ----  -------  ---- 
 (1) Relevant securities 
                                              -------  ----  -------  ---- 
 (2) Derivatives (other than options) 
                                              -------  ----  -------  ---- 
 (3) Options and agreements to purchase/sell 
                                              -------  ----  -------  ---- 
 Total 
                                              -------  ----  -------  ---- 
 
   3.    DEALINGS (Note 3) 

(a) Purchases and sales

 
 Purchase/sale               Number of relevant securities   Price per unit (Note 4) 
 Sale (Borrow Full Return)             1,073,889                       N/A 
                            ------------------------------  ------------------------ 
   Purchase (Borrow New)                  954                          N/A 
                            ------------------------------  ------------------------ 
   Purchase (Borrow New)                  954                          N/A 
                            ------------------------------  ------------------------ 
 

(b) Derivatives transactions (other than options transactions)

 
 Product name, e.g.   Nature of transaction   Number of relevant securities   Price per unit 
  CFD                        (Note 5)                    (Note 6)                (Note 4) 
 
 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

 
 Product name,e.g.   Writing, selling,       Number of        Exercise       Type, e.g.       Expiry    Option money 
  call option           purchasing,          securities         price    American, European    date     paid/received 
                          varying           to which the                        etc.                    per unit (Note 
                           etc.                option                                                         4) 
                                          relates (Note 7) 
 
 
   (ii)            Exercising 
 
 Product name,e.g. call option   Number of securities   Exercise price per unit (Note 
                                                                      4) 
 
 
   (d)            Other dealings (including transactions in respect of new securities)  (Note 3) 
 
 Nature of transaction (Note 7)   Details   Price per unit (if applicable) (Note 4) 
 
 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 
 Full details of any agreement, arrangement or understanding between the person disclosing 
  and any other person relating to the voting rights of any relevant securities under 
  any option referred to on this form or relating to the voting rights or future acquisition 
  or disposal of any relevant securities to which any derivative referred to on this 
  form is referenced. If none, this should be stated. 
                                            NONE 
 
   Is a Supplemental Form 8 attached? (Note 9)        NO 
 
 Date of disclosure                                         13 August 2021 
 Contact name                                       Paul Grainger and Kashif Rafiq 
                                                -------------------------------------- 
 Telephone number                                [phone] / [phone] 
                                                -------------------------------------- 
 Name of offeree/offeror with which connected             UDG HEALTHCARE PLC 
                                                -------------------------------------- 
 Nature of connection (Note 9)                            Advisor to Offeree 
                                                -------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEPJMLTMTJBMFB

(END) Dow Jones Newswires

August 13, 2021 05:37 ET (09:37 GMT)